Intrinsiqs

Is Dyne Therapeutics, Inc. overvalued?

Dyne Therapeutics, Inc. (DYN) — key valuation metrics and fundamentals.

No verdict
Price
$17.16
Fair value
—
Current P/E
—
Normal P/E
45.0
Market cap
$3.22B
Dividend yield
0.0%
Return on equity
-69.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DYN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.